ÂÜÀòÂÒÂ×

Erin Riegler is an experienced associate scientist currently employed at BridgeBio since September 2021. Prior roles include serving as a scientist at Chimera Bioengineering from August 2019 to August 2021 and holding positions as associate scientist and senior research associate at Theravance Biopharma US, Inc. between March 2017 and August 2019. Prior to that, Erin Riegler worked as a senior research associate at FLX Bio, Inc. from May 2016 to February 2017, and as a research associate at Reset Therapeutics from July 2013 to April 2016. Additional experience includes a role as a research technician at Genentech and a research associate position at Catalyst Biosciences, focusing on animal studies and pre-clinical experiments in various therapeutic areas. Erin Riegler holds a Bachelor of Science degree in Biopsychology from UC Santa Barbara.